Current Status of Epidemiology, Diagnosis, Therapeutics, and Vaccines for Novel Coronavirus Disease 2019 (COVID-19)

21 avril 2020

Source : jmb

Auteur :Dae-Gyun Ahn and al.


Coronavirus disease 2019 (COVID-19) causing serious respiratory illness such as pneumonia and lung failure was firstly reported in Wuhan city, the capital of Hubei, China. The etiological agent of COVID-19 has been confirmed as a novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is most likely transmitted from zoonotic coronaviruses, similar to SARS-CoV previously emerged in 2002. Within a few months of the first report, SARS-CoV-2 has spread across China and worldwide, reaching a pandemic level. As COVID-19 has triggered enormous human casualties and serious economic loss posing global threats, it is urgent to understand the ongoing situation and to build strategies to contain the viral spread. Currently, various diagnostic kits for testing COVID-19 are available and several repurposing therapeutics for COVID-19 have shown to be clinically effective. In addition, global institutions and companies have begun to develop vaccines for the prevention of COVID-19. Here, we review current status of epidemiology, diagnosis, treatment, and vaccine development for the COVID-19.

Télécharger l’article complet

© Les Hôpitaux Universitaires de Strasbourg 2020 - Tous droits réservés